Stock Yards Bank & Trust Co. Cuts Stock Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Stock Yards Bank & Trust Co. trimmed its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 18.0% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 16,427 shares of the pharmacy operator’s stock after selling 3,603 shares during the quarter. Stock Yards Bank & Trust Co.’s holdings in Walgreens Boots Alliance were worth $429,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently bought and sold shares of WBA. Vanguard Group Inc. grew its holdings in Walgreens Boots Alliance by 14.5% during the third quarter. Vanguard Group Inc. now owns 86,675,198 shares of the pharmacy operator’s stock valued at $1,927,656,000 after purchasing an additional 10,962,030 shares during the last quarter. Invesco Ltd. increased its stake in shares of Walgreens Boots Alliance by 21.5% in the third quarter. Invesco Ltd. now owns 17,026,420 shares of the pharmacy operator’s stock worth $378,668,000 after purchasing an additional 3,013,807 shares during the period. Morgan Stanley grew its holdings in Walgreens Boots Alliance by 15.8% in the 3rd quarter. Morgan Stanley now owns 12,584,371 shares of the pharmacy operator’s stock valued at $279,876,000 after buying an additional 1,720,228 shares during the last quarter. International Assets Investment Management LLC increased its position in Walgreens Boots Alliance by 1,985.1% in the 4th quarter. International Assets Investment Management LLC now owns 889,546 shares of the pharmacy operator’s stock worth $23,226,000 after buying an additional 846,884 shares during the period. Finally, Grantham Mayo Van Otterloo & Co. LLC lifted its holdings in shares of Walgreens Boots Alliance by 85.1% during the third quarter. Grantham Mayo Van Otterloo & Co. LLC now owns 1,752,170 shares of the pharmacy operator’s stock worth $38,968,000 after buying an additional 805,332 shares during the last quarter. Institutional investors and hedge funds own 58.59% of the company’s stock.

Insider Activity at Walgreens Boots Alliance

In other news, Director Inderpal S. Bhandari acquired 3,000 shares of Walgreens Boots Alliance stock in a transaction on Thursday, April 11th. The stock was acquired at an average cost of $18.05 per share, with a total value of $54,150.00. Following the transaction, the director now owns 3,000 shares of the company’s stock, valued at approximately $54,150. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In other news, CFO Manmohan Mahajan acquired 6,000 shares of the firm’s stock in a transaction that occurred on Tuesday, April 2nd. The stock was bought at an average cost of $19.38 per share, for a total transaction of $116,280.00. Following the acquisition, the chief financial officer now directly owns 166,969 shares in the company, valued at $3,235,859.22. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Inderpal S. Bhandari bought 3,000 shares of Walgreens Boots Alliance stock in a transaction on Thursday, April 11th. The stock was acquired at an average cost of $18.05 per share, with a total value of $54,150.00. Following the acquisition, the director now owns 3,000 shares in the company, valued at approximately $54,150. The disclosure for this purchase can be found here. Insiders have bought 13,456 shares of company stock valued at $270,423 over the last ninety days. Corporate insiders own 17.40% of the company’s stock.

Walgreens Boots Alliance Price Performance

Shares of WBA opened at $18.05 on Wednesday. The company has a market capitalization of $15.57 billion, a price-to-earnings ratio of -2.58, a price-to-earnings-growth ratio of 1.13 and a beta of 0.73. The business has a 50-day moving average of $20.26 and a 200-day moving average of $21.86. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.66 and a quick ratio of 0.32. Walgreens Boots Alliance, Inc. has a 1 year low of $17.51 and a 1 year high of $35.54.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings results on Thursday, March 28th. The pharmacy operator reported $1.20 earnings per share for the quarter, topping analysts’ consensus estimates of $0.82 by $0.38. Walgreens Boots Alliance had a positive return on equity of 12.11% and a negative net margin of 4.18%. The firm had revenue of $37.05 billion during the quarter, compared to the consensus estimate of $35.86 billion. During the same period last year, the business posted $1.16 EPS. The business’s revenue was up 6.3% compared to the same quarter last year. As a group, equities research analysts anticipate that Walgreens Boots Alliance, Inc. will post 3.23 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on the company. TD Cowen decreased their price objective on Walgreens Boots Alliance from $37.00 to $35.00 and set a “buy” rating on the stock in a report on Wednesday, April 3rd. UBS Group dropped their price target on shares of Walgreens Boots Alliance from $25.00 to $22.00 and set a “neutral” rating for the company in a research report on Wednesday, April 3rd. Barclays assumed coverage on Walgreens Boots Alliance in a research report on Wednesday, January 3rd. They set an “underweight” rating and a $21.00 target price for the company. Bank of America decreased their price objective on shares of Walgreens Boots Alliance from $23.00 to $22.00 and set an “underperform” rating on the stock in a research note on Tuesday, March 26th. Finally, Truist Financial restated a “hold” rating and set a $25.00 price target on shares of Walgreens Boots Alliance in a research report on Monday, April 1st. Four equities research analysts have rated the stock with a sell rating, ten have given a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat, Walgreens Boots Alliance has a consensus rating of “Hold” and a consensus price target of $24.36.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.